Ricevi le ultime notizie sulle azioni GRAIL con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di GRAL

Ultime notizie per

GRAIL

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Jim Cramer Photo by s_bukley on Shutterstock

Markets

Media

GRAL

MRNA

Le oscillazioni di Wall Street non accennano a diminuire. Il noto analista punta il dito contro la Casa Bianca e le sue politiche commerciali.

Jim Cramer accusa Trump: &#34;Il mercato è volatile? Solo se il presidente vuole&#34;

Jim Cramer Reacts To Friday Market Plunge And Hints At His Next Buy

Mid Cap

ANET

RBRK

SHAK

TMDX

L&#39;esperto di Mad Money si esprime: quali titoli meritano attenzione e quali no? Analisi e consigli per gli investitori.

Jim Cramer: ecco le azioni che consiglia di comprare (e da evitare)

Long Ideas

News

Trading Ideas

CTRA

Analisi dei consigli dell&#39;esperto di finanza, con focus su opportunità e valutazioni di mercato nel settore energetico e finanziario.

Jim Cramer: BlackRock è un&#39;opportunità, Coterra Energy è la più economica

GRAIL Inc

GRAIL INC COM

Press Releases

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

Opinion

With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology

GRAIL to Announce Second Quarter 2025 Financial Results

GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

Earnings

GRAIL Reports Second Quarter 2025 Financial Results

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC

IMRX

INTS

ONCY

RLAY

TSX:ONC

Agios Pharmaceuticals, Inc. - Common Stock

Agios Pharmaceuticals

Alvotech

Apogee Therapeutics

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

Beam Therapeutics

Cidara Therapeutics

Celcuity

Cogent Biosciences

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Denali Therapeutics

Dyne Therapeutics

89bio

Amicus Therapeutics

Galapagos NV - American Depositary Shares

Galapagos

ImmunityBio

IDEAYA Biosciences

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Disc Medicine

Mesoblast Limited - American Depositary Shares

Mesoblast

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vera Therapeutics, Inc. - Class A Common Stock

Comments

GRAIL Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO